FOXC1 and pancreatic ductal adenocarcinoma: Previous research supports the notion that FOXC1 functions as a negative prognostic factor; elevated expression of FOXC1 has been associated with poor prognosis in multiple malignancies, such as, hepatocellular carcinoma, pancreatic ductal adenocarcinoma, gastric cancer, and breast cancer [51].